In this Spotlight feature, we investigate whether the bacteria that live in our guts could influence our blood pressure. If so, could they guide future treatment?
Hypertension is growing in prevalence, but can we blame gut bacteria?
Scientists are growing increasingly interested in the role of gut bacteria.
Each week, journals publish many study papers that examine how these microscopic visitors might play a role in health and disease.
As it stands, because the microbiome is a relatively new field of study, the full scope of gut bacteria’s role in health is still up for debate.
However, it is becoming increasingly clear that the bacteria in our gut can open new avenues in our understanding of a wide range of conditions.
Because of this, it is vital that medical scientists unearth the various mechanisms that underpin blood pressure regulation.
Although researchers have established certain risk factors for hypertension — such as smoking, obesity, and drinking excessive amounts of alcohol — there appears to be more to the condition.
More than 19% of the U.S. adults with hypertension have a treatment-resistant form of the condition, wherein medications do not bring blood pressure down to a healthful level. Also, lifestyle interventions do not work for everyone.
Some scientists are considering dysfunction of the immune system and autonomic nervous system. This is the branch of the nervous system that controls “automatic” functions, such as breathing, digestion, and blood pressure.
A relatively new addition to this list of potential risk factors is gut dysbiosis, which refers to an imbalanced microbial community.
A study in the journal
Prehypertension refers to high blood pressure that is not yet high enough for a person to receive a diagnosis of hypertension. People in this range have an increased risk of developing hypertension in the future.
They found that in the participants with prehypertension or hypertension, there was a reduction in the diversity of gut bacteria. In particular, species such as Prevotella and Klebsiella tended to be overgrown.
Next, the scientists transplanted fecal matter from the participants into germ-free mice, which are animals that lack gut bacteria. The mice that received fecal matter from people with hypertension also developed hypertension.
Conversely, the authors of a 2019 study in the journal Frontiers in Physiology transplanted feces from mice without hypertension into mice with hypertension. This resulted in a reduction in blood pressure in the mice with hypertension.
Another study investigated the bacterial residents of pregnant women with obesity and overweight pregnant women, both of whom are at increased risk of hypertension. They found that in both sets of participants, bacteria of the genus Odoribacter were significantly rarer.
Those with the lowest levels of Odoribacter had the highest blood pressure readings.
Although evidence is mounting that gut bacteria can influence hypertension, most of the studies to date have been observational.
This means that it has not been possible to determine whether changes in gut bacteria influence blood pressure, or whether hypertension (or the factors that produce it) alter gut bacteria.
Also, it is still unclear exactly how gut bacteria drive these changes.
Although the gut and blood pressure might not seem like obvious companions, the connection is not, perhaps, so surprising.
Many of the factors that increase the risk of hypertension — such as the consumption of alcohol and salty food — enter the body through the digestive system.
Nutrients, along with certain chemicals that bacteria produce, have the opportunity to enter the blood supply; once in circulation, the body is their oyster.
Also, the gastrointestinal tract hosts a number of processes that have the potential to play a role in hypertension, including metabolism, the production of hormones, and a direct connection with the nervous system.
Short chain fatty acids
Some researchers believe that one of the links between the gut and hypertension could be short chain fatty acids (SCFAs). Some gut bacteria produce these molecules as they digest dietary fiber.
After bacteria have produced SCFAs, the host’s blood suppy absorbs them. SCFAs affect a range of physiological processes, one of which
Backing this theory up, one study found differences in gut bacterial populations between participants with and without hypertension. Individuals with higher blood pressure had lower levels of certain species that produce SCFAs, including Roseburia spp. and Faecalibacterium prausnitzii.
One paper in the journal
The scientists simulated sleep apnea in rats. To so do, they fed half of the rats a standard diet and the other half a high fat diet. Hypertension only appeared in the rats that ate the fatty diet.
Next, they assessed the mice’s microbiome and found that the high fat group had a significant reduction in numbers of bacteria responsible for producing SCFAs.
Finally, the scientists transplanted bacteria from the hypertensive rats into the rats who ate a normal diet and demonstrated normal blood pressure.
This fecal transplant produced hypertension in the previously healthy animals.
Most likely, if gut bacteria truly do have the power to produce hypertension, it is likely to be via a number of interlinked routes. Scientists have several theories. For instance,
Studies have shown that hypertension is associated with increased sympathetic nerve activity (a branch of the autonomic nervous system). This increases gut permeability.
If the gut walls become more permeable, it is easier for the gut’s contents to leak through into the rest of the body.
This change in permeability impacts the gut environment and alters the microbiome. At the same time, bacterial products can pass more easily into the blood.
Interestingly, other factors — including smoking tobacco and being stressed — also alter the sympathetic system. This could help provide further reasons why these factors can also lead to cardiovascular changes.
Designing a probiotic that reliably reduces high blood pressure will take some time, but some researchers are looking at this option.
“[P]robiotic fermented milk has blood pressure-lowering effects in prehypertensive and hypertensive [people].”
A 2014 systematic review and meta-analysis investigated probiotics more generally. Its authors only included randomized controlled trials, and their search only turned up nine papers that fit their criteria.
Overall, they concluded, “The present meta-analysis suggests that consuming probiotics may improve [blood pressure] by a modest degree.”
They also noted that the effect appeared to be more pronounced for people whose initial blood pressure readings were high, when the study used multiple bacterial species, and when the researchers tested the intervention for more than 8 weeks.
In the current scientific climate, the public has a substantial appetite for probiotics; however, outside of a small number of specific conditions, there is little evidence that they can benefit human health substantially or reliably.
With that in mind, it is likely to be a long time before a probiotic will bring blood pressure down.
Science is relatively new to the question of gut bacteria’s impact on blood pressure, so plenty more work will be needed. Although some evidence now supports the interaction between gut bacteria and hypertension, it is a complex beast to dissect.
Our diet, the drugs we take (particularly antibiotics), other health conditions we might have, and many more variables can all influence our gut bacteria.
Bacteriophages (viruses that attack bacteria), fungi, and parasites also find a home in the gut and influence both bacterial populations and our physiology.
This mystery will only unravel slowly, but at least the wheels of research are now in motion. As one reviewer writes:
“Evidence is rapidly accumulating implicating gut dysbiosis in hypertension. However, we are far from understanding whether this is a cause or consequence of [hypertension], and how to best translate this fundamental knowledge to advance the management of [hypertension].”